Showing results (21-30 of 312) with videos related to

Sort By:
Pageof 32
Eye (London, England)|December 3, 2025
Impact of baseline visual acuity, time-in-range and early treatment on functional outcomes in DMO: insights from the IRISS outcomesIgor Kozak, Ramin Khoramnia, Simon R Taylor, et al.
Journal of Virology|May 9, 2008
Epstein-Barr virus SM protein functions as an alternative splicing factorDinesh Verma, Sankar Swaminathan
Ophthalmology and Therapy|January 31, 2022
Update on Current and Future Management for Diabetic MaculopathyPatricia Udaondo, Mariacristina Parravano, Stela Vujosevic, et al.
Expert Opinion on Drug Safety|December 10, 2014
Systemic safety of anti-VEGF drugs: a commentaryLauren J Scott, Usha Chakravarthy, Barnaby C Reeves, et al.
JAMA Ophthalmology|January 13, 2018
Disorganization of Inner Retina and Outer Retinal Morphology in Diabetic Macular EdemaRadha Das, Gareth Spence, Ruth E Hogg, et al.
International Journal of Retina and Vitreous|January 30, 2019
Spontaneous retinal pigment epithelial tear in type 2 choroidal neovascularization: repair mechanisms following anti-VEGF therapyGiuseppe Casalino, Vasuki Sivagnanavel, Samir Dowlut, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2016
Spironolactone blocks Epstein-Barr virus production by inhibiting EBV SM protein functionDinesh Verma, Jacob Thompson, Sankar Swaminathan
Current Eye Research|August 21, 2002
The effects of high ambient glucose on the radiosensitivity of retinal microvascular endothelial cells and pericytesWilliam Patton, Heather Gillespie, Leslie Frew, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 19, 2021
Treatment patterns and persistence rates with anti-vascular endothelial growth factor treatment for diabetic macular oedema in the UK: A real-world studyTunde Peto, Toks Akerele, Alexandros Sagkriotis, et al.
Pageof 32